The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
Abstract
The mechanism of tumor-associated T cell dysfunction remains an unresolved problem of tumor immunology. Development of T cell defects in tumor-bearing hosts are often associated with increased production of immature myeloid cells. In tumor-bearing mice, these immature myeloid cells are represented by a population of Gr-1+ cells. In this study we investigated an effect of these cells on T cell function. Gr-1+ cells were isolated from MethA sarcoma or C3 tumor-bearing mice using cell sorting. These Gr-1+ cells expressed myeloid cell marker CD11b and MHC class I molecules, but they lacked expression of MHC class II molecules. Tumor-induced Gr-1+ cells did not affect T cell responses to Con A and to a peptide presented by MHC class II. In sharp contrast, Gr-1+ cells completely blocked T cell response to a peptide presented by MHC class I in vitro and in vivo. Block of the specific MHC class I molecules on the surface of Gr-1+ cells completely abrogated the observed effects of these cells. Thus, immature myeloid cells specifically inhibited CD8-mediated Ag-specific T cell response, but not CD4-mediated T cell response. Differentiation of Gr-1+ cells in the presence of growth factors and all-trans retinoic acid completely eliminated inhibitory potential of these cells. This may suggest a new approach to cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Self-citationGabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., & Carbone, D. P. (1998) · Blood · doi:10.1182/blood.v92.11.4150 · Cited by 1,048
Self-citationFeltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., De Jongh, B. M., Drijfhout, J. W., Schegget, J. T., Melief, C. J. M., & Kast, W. M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230929 · Cited by 825
Self-citationWarrell, R. P., de The, H., Wang, Z.-Y., & Degos, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290307 · Cited by 776
He, L.-Z., Figueiredo-Pontes, L. L., Rego, E. M., & Pandolfi, P. P. (2015) · Encyclopedia of Cancer · doi:10.1007/978-3-662-46875-3_63 · Cited by 766
Clinical significance of defective dendritic cell differentiation in cancer.
Almand, B., Resser, J. R., Lindman, B. R., Nadaf, S., Clark, J. I., Kwon, E. D., Carbone, D. P., & Gabrilovich, D. I. (2000) · PubMed · Cited by 699
Self-citationBreitman, T., Collins, S., & Keene, B. (1981) · Blood · doi:10.1182/blood.v57.6.1000.1000 · Cited by 571
Kirberg, J., Baron, A., Jakob, S., Rolink, A., Karjalainen, K., & von Boehmer, H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.25 · Cited by 410
Sotomayor, E. M., Borrello, I., Tubb, E., Rattis, F.-M., Bien, H., Lu, Z., Fein, S., Schoenberger, S., & Levitsky, H. I. (1999) · Nature Medicine · doi:10.1038/10503 · Cited by 407
Self-citationDegos, L., Dombret, H., Chomienne, C., Daniel, M., Miclea, J., Chastang, C., Castaigne, S., & Fenaux, P. (1995) · Blood · doi:10.1182/blood.v85.10.2643.bloodjournal85102643 · Cited by 362
Kusmartsev, S. A., Li, Y., & Chen, S.-H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.779 · Cited by 355
Otsuji, M., Kimura, Y., Aoe, T., Okamoto, Y., & Saito, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13119 · Cited by 338
Bronte, V., Wang, M., Overwijk, W. W., Surman, D. R., Pericle, F., Rosenberg, S. A., & Restifo, N. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5313 · Cited by 312
Young, M. R., Newby, M., & Wepsic, H. T. (1987) · PubMed · Cited by 231
Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma.
Noguchi, Y., Richards, E. C., Chen, Y. T., & Old, L. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2219 · Cited by 212
Velders, M. P., Weijzen, S., Eiben, G. L., Elmishad, A. G., Kloetzel, P.-M., Higgins, T., Ciccarelli, R. B., Evans, M., Man, S., Smith, L., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5366 · Cited by 182
Self-citationA mouse mutant p53 product recognized by CD4+ and CD8+ T cells.
Noguchi, Y., Chen, Y. T., & Old, L. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3171 · Cited by 173
Feltkamp, M. C. W., Vreugdenhil, G. R., Vierboom, M. P. M., Ras, E., van der Burg, S. H., Schegget, J. T., Melief, C. J. M., & Kast, W. M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250935 · Cited by 166
Self-citationSotomayor, E. M., Borrello, I., Tubb, E. E., Allison, J. P., & Levitsky, H. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11476 · Cited by 157
Self-citationT Cell Recognition of Human Tumors: Implications for Molecular Immunotherapy of Cancer
Ioannides, C. G., & Whiteside, T. L. (1993) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1993.1012 · Cited by 148
Young, M. R., Wright, M. A., Matthews, J. P., Malik, I., & Prechel, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1916 · Cited by 142
Immunosuppressive Factors in Human Cancer
Sulitzeanu, D. (1992) · Advances in cancer research · doi:10.1016/s0065-230x(08)60827-1 · Cited by 128
Gratas, C., Menot, M. L., Dresch, C., & Chomienne, C. (1993) · PubMed · Cited by 83
Young, M. R., Wright, M. A., & Pandit, R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.990 · Cited by 83
Angulo, I., Rodríguez, R., García, B., Medina, M., Navarro, J. A., & Subiza, J. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.1.15 · Cited by 77
Watson, G. A., & Lopez, D. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.6.3124 · Cited by 61
Nitric Oxide Mediation of Active Immunosuppression Associated With Graft-Versus-Host Reaction
Bobé, P., Benihoud, K., Grandjon, D., Opolon, P., Pritchard, L. L., & Huchet, R. (1999) · Blood · doi:10.1182/blood.v94.3.1028.415k24_1028_1037 · Cited by 51
IL-12 and Mutant P53 Peptide-Pulsed Dendritic Cells for the Specific Immunotherapy of Cancer
Gabrilovich, D. I., Cunningham, H. T., & Carbone, D. P. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199611000-00005 · Cited by 39
Self-citation
Cited by
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Self-citationParadoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Myeloid-Derived Suppressor Cells
Gabrilovich, D. I. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0297 · Cited by 1,882
Self-citationMyeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736
Metadata
- Authors
- Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., & Kast, W. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-05-01
- Volume
- 166
- Issue
- 9
- Pages
- 5398-5406
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2134653497
- Cited by
- 538
- References
- 30
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.